Mode
Text Size
Log in / Sign up

Ten-session school-based mental health package reduces depressive and anxiety symptoms in Chinese adolescents compared to routine curriculum.

Ten-session school-based mental health package reduces depressive and anxiety symptoms in Chinese ad…
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider low-intensity school-based mental health packages for reducing adolescent depressive and anxiety symptoms.

This cluster-randomised controlled trial investigated the efficacy of a school-based mental health intervention among Chinese adolescents. The study was conducted across public schools in ten provinces in China, involving a total sample of 5,222 participants. The population consisted of adolescents with a mean age of 13.6 years, comprising 51.5% girls and 48.5% boys. The study design utilized a cluster-randomisation approach, assigning entire schools to either the intervention or control arm rather than randomising individual students. The intervention phase was not reported, and the specific publication type was not reported in the available data.

The intervention consisted of ten weekly sessions, each lasting 40 minutes, delivered by trained school-based mental health teachers or counsellors. These sessions utilized the Adolescent Mental Health Service Package (AMHSP), which was delivered using standardised manuals and multimedia materials. The comparator group received the routine school curriculum without any additional mental health content. This design aimed to test the feasibility and impact of integrating mental health promotion directly into the existing school schedule without requiring external specialists.

The primary outcomes assessed included depressive symptoms, anxiety symptoms, subjective wellbeing, and emotion regulation. At the one-month follow-up, the intervention group demonstrated significantly lower depressive symptoms relative to the control group. The effect size was a Standardised Mean Difference (SMD) of -0.09, with a 95% confidence interval ranging from -0.14 to -0.04 and a p-value of 0.0013. Similarly, anxiety symptoms were significantly lower in the intervention group compared to controls, with an SMD of -0.11, a 95% CI of -0.16 to -0.05, and a p-value of 0.0002.

Regarding secondary outcomes, no statistically significant differences were observed between groups for subjective wellbeing. The effect size for subjective wellbeing was an SMD of 0.02, with a 95% CI of -0.03 to 0.08 and a p-value of 0.85. Furthermore, the intervention did not result in significant differences in emotion regulation measures. Specifically, cognitive reappraisal showed an SMD of 0.03 (95% CI -0.02 to 0.09, p=0.33), and expressive suppression showed an SMD of -0.08 (95% CI -0.14 to -0.01, p=0.10). No absolute numbers were reported for these outcomes.

Safety and tolerability findings indicated that no adverse events were reported during the study period. Data on serious adverse events, discontinuations, and specific tolerability metrics were not reported. The study was funded by UNICEF. The authors noted a key methodological limitation: neither the students nor the facilitators were masked to the group allocation. This lack of blinding may introduce bias, although the cluster-randomised design and the nature of the intervention mitigate some concerns. The certainty of the evidence was not formally reported.

These results support the potential of a low-intensity, curriculum-integrated approach to promoting adolescent mental health. The study demonstrates a scalable strategy for early mental health promotion within the school setting, which is particularly relevant given the high prevalence of mental health issues in adolescents. However, the lack of masking and the absence of long-term follow-up data beyond one month limit the ability to draw definitive conclusions regarding sustained efficacy. Questions remain regarding the long-term maintenance of symptom reduction and the generalisability of these findings to other cultural or educational contexts. Clinicians should consider these findings as evidence supporting school-based mental health initiatives, while acknowledging the inherent limitations of the trial design.

Study Details

Study typeRct
Sample sizen = 2,620
EvidenceLevel 2
Follow-up1.0 mo
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: Mental health problems, including depression, anxiety, and suicide, pose a substantial burden on adolescents worldwide, making prevention a priority. In China, major challenges remain in implementing and evaluating school-based mental health programmes. The Adolescent Mental Health Service Package (AMHSP) is a multicomponent, culturally adapted, evidence-informed curriculum that is grounded in Positive Youth Development and designed to reduce depressive and anxiety symptoms and enhance mental wellbeing. The aim of this study was to evaluate the AMHSP for improving adolescent mental health in routine school settings. METHODS: This cluster-randomised controlled trial included public schools across ten provinces in China, with participants nested within schools and classrooms within each school randomly assigned 1:1 to either ten weekly 40-min AMHSP sessions (intervention), delivered by trained school-based mental health teachers or counsellors (facilitators) using standardised manuals and multimedia materials, or routine curriculum without additional mental health content (control). Given the nature of the school-based intervention, neither students nor facilitators were masked to group allocation, but all statistical analyses were done by an independent statistician masked to group allocation, and student self-report data were collected anonymously using secure, standardised platforms. The four primary outcomes were depressive symptoms (measured by nine-item Patient Health Questionnaire), anxiety symptoms (seven-item Generalized Anxiety Disorder Scale), subjective wellbeing (WHO Five-item Well-Being Index), and emotion regulation (ten-item Emotion Regulation Questionnaire, assessing both cognitive reappraisal and expressive suppression), which were self-reported at baseline, immediately after intervention, and at 1-month and 3-month follow-up. The primary outcome analysis of change from baseline at 3 months' follow-up in the four coprimary outcomes was analysed by linear mixed-effects models in the intention-to-treat population, which included all participants who completed at least one assessment. To control for multiple testing, we prespecified the use of the Benjamini-Hochberg false discovery rate (FDR) correction of p values. This trial was prospectively registered with the Chinese Clinical Trial Registry (ChiCTR2300076956) and has been completed. FINDINGS: Between Oct 12, 2023 and Oct 10, 2024, 5222 students from 120 classrooms in 18 public schools (mean age 13·6 years [SD 1·7]; 2687 [51·5%] girls and 2535 [48·5%] boys) were randomly assigned to the AMHSP intervention (n=2620) or control (n=2602), completed the baseline assessments, and were included in the primary outcome analysis. At 3 months, the AMHSP intervention group showed lower depressive symptoms (standardised mean difference [SMD] -0·09 [95% CI -0·14 to -0·04], p=0·0013) and anxiety symptoms (-0·11 [-0·16 to -0·05], p=0·0002) relative to the control group. No differences were seen in subjective wellbeing (SMD 0·02 [-0·03 to 0·08], p=0·85) or emotion regulation (cognitive reappraisal SMD 0·03 [-0·02 to 0·09], p=0·33; expressive suppression -0·08 [-0·14 to -0·01], p=0·10) at 3 months. No adverse events were reported. INTERPRETATION: The reduction in depression and anxiety symptoms 3 months after completing ten AMHSP sessions indicates a slow but meaningful benefit of the programme and supports the potential of a low-intensity, curriculum-integrated approach to promoting adolescent mental health. Delivery of the AMHSP by trained school-based mental health teachers demonstrates a scalable strategy for early mental health promotion in schools. FUNDING: UNICEF.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.